Professor, China Pharmceutical University, China
Zhenghong Wu is a professor in pharmaceutics and a vice Chair of the Nanjing Pharmaceutical Association, also a licensed Pharmacists in China. Dr. Wu is a member of several journal editorial boards, and is a reviewer for over a dozen pharmaceutical and drug delivery journals. He also serves as a reviewer for the National Natural Science Foundation of China, and China Academic Degrees & Graduate Education Development Center of the Ministry of Education.
Prof. Wu received his Ph.D. (pharmaceutics, in 2003) and M.S. (pharmaceutical analysis, in 1997) from China Pharmaceutical University (Nanjing, China), B.S. (pharmacy, in 1990) from Shanghai Medical University (Shanghai, China). He worked as vice dean of Pharmacy School in Xinjiang Medical University (Ürümqi, China) from 2014 to 2016, as visiting scholar in Rutgers University (USA) from 2012 to 2013, as assistant mayor in Taixing Municipal Government of Jiangsu Province from 2010 to 2011, as postdoctoral fellow in Academy of Military Medical Science (Beijing, China) from 2003 to 2005. He served as clinical pharmacist in the First Affiliated Hospital of Anhui Medical University (Hefei, China) from 1990 to 1994, in the Drum Tower Hospital Affiliated to Nanjing University (Nanjing, China) from 1997 to 2003. He joined the Department of Pharmaceutics, China Pharmaceutical University (Nanjing, China) as assistant professor in 2003, and later became associate professor in 2005. From 2006 to 2016, He served as deputy director of the Experiment Center for Pharmacy. Currently, he is working as Professor.
Dr Wu has published more than 150 publications including papers, book and textbook chapters, conference proceedings, and patents. He has trained more than 60 PhD/MS students, and visiting scholars. His research is supported by grants from the National Basic Research Program of China, the National Natural Science Foundation of China, and other national sources.
His group?s main research focus lies in the area of biopharmaceutics, targeted drug delivery, nanotechnology (polymers, dendrimers, liposomes, etc.) for cancer treatment, molecular targeting; use of macromolecules for drug delivery, modified-release preparations.